131 related articles for article (PubMed ID: 38114772)
1. In Vivo Cancer Microenvironment Responsive Glycan Receptor-Targeted Nanoparticles for Gemcitabine Delivery to Benzo[a]pyrene-Induced Lung Cancer Model.
Kumar K; Verma R; Manjit ; Priya ; Mishra M; Rani V; Chawla R
AAPS PharmSciTech; 2023 Dec; 25(1):2. PubMed ID: 38114772
[TBL] [Abstract][Full Text] [Related]
2. Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer.
Kumar K; Rawat SG; Manjit ; Mishra M; Priya ; Kumar A; Chawla R
Int J Biol Macromol; 2023 Sep; 249():126057. PubMed ID: 37524283
[TBL] [Abstract][Full Text] [Related]
3. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.
Wang F; Wang Y; Ma Q; Cao Y; Yu B
Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196
[TBL] [Abstract][Full Text] [Related]
5. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
6. EGFR Targeted Redox Sensitive Chitosan Nanoparticles of Cabazitaxel: Dual-Targeted Cancer Therapy, Lung Distribution, and Targeting Studies by Photoacoustic and Optical Imaging.
Vikas ; Mehata AK; Viswanadh MK; Malik AK; Setia A; Kumari P; Mahto SK; Muthu MS
Biomacromolecules; 2023 Nov; 24(11):4989-5003. PubMed ID: 37871263
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery.
Bhattacharya S; Anjum MM; Patel KK
Drug Deliv; 2022 Dec; 29(1):1060-1074. PubMed ID: 35363113
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
[TBL] [Abstract][Full Text] [Related]
9. Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant.
Mehrabi M; Dounighi NM; Rezayat Sorkhabadi SM; Doroud D; Amani A; Khoobi M; Ajdary S; Pilehvar-Soltanahmadi Y
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):230-240. PubMed ID: 29260901
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer model.
Vikas ; Mehata AK; Suseela MNL; Behera C; Kumari P; Mahto SK; Muthu MS
Int J Biol Macromol; 2022 Nov; 221():874-890. PubMed ID: 36089091
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers.
Şenyiğit ZA; Karavana SY; İlem-Özdemir D; Çalışkan Ç; Waldner C; Şen S; Bernkop-Schnürch A; Baloğlu E
Int J Nanomedicine; 2015; 10():6493-507. PubMed ID: 26508855
[TBL] [Abstract][Full Text] [Related]
12. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
Nasri N; Saharkhiz S; Dini G; Yousefnia S
Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
[TBL] [Abstract][Full Text] [Related]
14. Sialic Acid Conjugated Chitosan Nanoparticles: Modulation to Target Tumour Cells and Therapeutic Opportunities.
Rana R; Rani S; Kumar V; Nakhate KT; Ajazuddin ; Gupta U
AAPS PharmSciTech; 2021 Dec; 23(1):10. PubMed ID: 34862568
[TBL] [Abstract][Full Text] [Related]
15. Lomustine loaded chitosan nanoparticles: characterization and in-vitro cytotoxicity on human lung cancer cell line L132.
Mehrotra A; Nagarwal RC; Pandit JK
Chem Pharm Bull (Tokyo); 2011; 59(3):315-20. PubMed ID: 21372411
[TBL] [Abstract][Full Text] [Related]
16. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study.
Hosseinzadeh H; Atyabi F; Dinarvand R; Ostad SN
Int J Nanomedicine; 2012; 7():1851-63. PubMed ID: 22605934
[TBL] [Abstract][Full Text] [Related]
18. Targeted Delivery System Based on Gemcitabine-Loaded Silk Fibroin Nanoparticles for Lung Cancer Therapy.
Mottaghitalab F; Kiani M; Farokhi M; Kundu SC; Reis RL; Gholami M; Bardania H; Dinarvand R; Geramifar P; Beiki D; Atyabi F
ACS Appl Mater Interfaces; 2017 Sep; 9(37):31600-31611. PubMed ID: 28836425
[TBL] [Abstract][Full Text] [Related]
19. Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer.
Zhang R; Ru Y; Gao Y; Li J; Mao S
Drug Des Devel Ther; 2017; 11():2631-2642. PubMed ID: 28919713
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-
Mehata AK; Singh V; Vikas ; Singh N; Mandal A; Dash D; Koch B; Muthu MS
ACS Appl Mater Interfaces; 2023 Jul; 15(29):34343-34359. PubMed ID: 37433149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]